Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-07

Clinical Trial Update: The Effect of Oral Zinc Supplementation on Thiol Oxido-reductive Index [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial assessed whether oral zinc supplementation alters the thiol oxido-reductive index in men with asthenozoospermia; the study is report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZINC (Zinc chloride)

Snippet

Sponsor: mahmoud hussein hadwan | Conditions: Asthenozoospermia | Phase 2 | Status: COMPLETED